Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the views of patients' and their family about patient-initiated follow-up in head and neck cancer: A mixed methods study.
Lorenc A, Greaves C, Duda J, Brett J, Matheson L, Fulton-Lieuw T, Secher D, Rhodes P, Ozakinci G, Nankivell P, Mehanna H, Jepson M; PETNECK2 Research Team. Lorenc A, et al. Among authors: fulton lieuw t. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13641. doi: 10.1111/ecc.13641. Epub 2022 Jul 4. Eur J Cancer Care (Engl). 2022. PMID: 35789510 Free PMC article.
Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study.
Vreugdenhil M, Fong C, Iqbal G, Roques T, Evans M, Palaniappan N, Yang H, O'Toole L, Sanghera P, Nutting C, Foran B, Sen M, Al Booz H, Fulton-Lieuw T, Dalby M, Dunn J, Hartley A, Mehanna H. Vreugdenhil M, et al. Clin Oncol (R Coll Radiol). 2021 Dec;33(12):795-803. doi: 10.1016/j.clon.2021.07.009. Epub 2021 Jul 30. Clin Oncol (R Coll Radiol). 2021. PMID: 34340917
Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials.
Rischin D, Mehanna H, Young RJ, Bressel M, Dunn J, Corry J, Soni P, Fulton-Lieuw T, Iqbal G, Kenny L, Porceddu S, Wratten C, Robinson M, Solomon BJ; Trans-Tasman Radiation Oncology Group and the De-ESCALaTE HPV Trial Group. Rischin D, et al. Ann Oncol. 2022 Aug;33(8):804-813. doi: 10.1016/j.annonc.2022.04.074. Epub 2022 May 4. Ann Oncol. 2022. PMID: 35525376 Free article.
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
Evaluation of US Elastography in Thyroid Nodule Diagnosis: The ElaTION Randomized Control Trial.
Mehanna H, Sidhu PS, Madani G, Woolley R, Boelaert K, Nankivell P, Da Forno P, Moreman K, Palmer A, Fulton-Lieuw T, Sharma N, Taylor J, Rajaguru K, Bekker J, Vaidhyanath R, Rehman T, Deeks J. Mehanna H, et al. Among authors: fulton lieuw t. Radiology. 2024 Oct;313(1):e240705. doi: 10.1148/radiol.240705. Radiology. 2024. PMID: 39404634 Clinical Trial.
Diagnostic performance of ultrasound vs. ultrasound-guided FNAc in thyroid nodules: data from the ElaTION trial.
Mehanna H, Nankivell P, Boelaert K, Woolley R, Sharma N, Sidhu PS, Madani G, Da Forno P, Moreman C, Palmer A, Fulton-Lieuw T, Taylor J, Rajaguru K, Bekker J, Vaidhyanath R, Rehman T, Deeks J. Mehanna H, et al. Among authors: fulton lieuw t. J Clin Endocrinol Metab. 2024 Oct 3:dgae682. doi: 10.1210/clinem/dgae682. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39359050
Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.
Nankivell P, Gaunt P, Gaunt C, Sissons J, Liaskou E, Jefferson Y, Fulton-Lieuw T, Mittal S, Mehanna H; PETNECK2 Research Team. Nankivell P, et al. Among authors: fulton lieuw t. BMC Cancer. 2024 Jul 18;24(1):861. doi: 10.1186/s12885-024-12639-2. BMC Cancer. 2024. PMID: 39026293 Free PMC article. No abstract available.
15 results